BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck
40 results:

  • 1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary cancer.
    Chinchilla-Tábora LM; Montero JC; Corchete LA; González-Morais I; Del Barco Morillo E; Olivares-Hernández A; Rodríguez González M; Sayagués JM; Ludeña MD
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
    Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease.
    Ichinokawa H; Takamochi K; Fukui M; Hattori A; Matsunaga T; Suzuki K
    Thorac Cancer; 2022 Jul; 13(14):2024-2030. PubMed ID: 35637601
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Asparagine enhances lck signalling to potentiate CD8
    Wu J; Li G; Li L; Li D; Dong Z; Jiang P
    Nat Cell Biol; 2021 Jan; 23(1):75-86. PubMed ID: 33420490
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications.
    Grześk G; Woźniak-Wiśniewska A; Błażejewski J; Górny B; Wołowiec Ł; Rogowicz D; Nowaczyk A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396592
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Correlation in gene expression between the aggravation of chronic obstructive pulmonary disease and the occurrence of complications.
    Cai Y; Liu R; Lu X; Zhang Q; Wang X; Lian H; Wang H
    Bioengineered; 2020 Dec; 11(1):1245-1257. PubMed ID: 33108241
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.
    Finkernagel F; Reinartz S; Schuldner M; Malz A; Jansen JM; Wagner U; Worzfeld T; Graumann J; von Strandmann EP; Müller R
    Theranostics; 2019; 9(22):6601-6617. PubMed ID: 31588238
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cancer adjuvant chemotherapy prediction model for non-small cell lung cancer.
    Alanni R; Hou J; Azzawi H; Xiang Y
    IET Syst Biol; 2019 Jun; 13(3):129-135. PubMed ID: 31170692
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells inhibit T cell activation through nitrating lck in mouse cancers.
    Feng S; Cheng X; Zhang L; Lu X; Chaudhary S; Teng R; Frederickson C; Champion MM; Zhao R; Cheng L; Gong Y; Deng H; Lu X
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10094-10099. PubMed ID: 30232256
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Aberrant lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice.
    Gulati P; Rühl J; Kannan A; Pircher M; Schuberth P; Nytko KJ; Pruschy M; Sulser S; Haefner M; Jensen S; Soltermann A; Jungraithmayr W; Eisenring M; Winder T; Samaras P; Tabor A; Stenger R; Stupp R; Weder W; Renner C; Münz C; Petrausch U
    Clin Cancer Res; 2018 Aug; 24(16):3981-3993. PubMed ID: 29748183
    [No Abstract]    [Full Text] [Related]  

  • 11. Bioinformatics methods for identifying differentially expressed genes and signaling pathways in nano-silica stimulated macrophages.
    Zhang L; Hao C; Li J; Qu Y; Bao L; Li Y; Yue Z; Zhang M; Yu X; Chen H; Zhang J; Wang D; Yao W
    Tumour Biol; 2017 Jun; 39(6):1010428317709284. PubMed ID: 28653889
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell lung cancer.
    Sakamoto S; Yamada T; Terazaki Y; Yoshiyama K; Sugawara S; Takamori S; Matsueda S; Shichijo S; Yamada A; Noguchi M; Itoh K; Hattori N; Kohno N; Sasada T
    Clin Lung Cancer; 2017 Nov; 18(6):e385-e394. PubMed ID: 28416261
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.
    Iglesia MD; Parker JS; Hoadley KA; Serody JS; Perou CM; Vincent BG
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27335052
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. RNA-Seq analysis of non-small cell lung cancer in female never-smokers reveals candidate cancer-associated long non-coding RNAs.
    Li J; Bi L; Shi Z; Sun Y; Lin Y; Shao H; Zhu Z
    Pathol Res Pract; 2016 Jun; 212(6):549-54. PubMed ID: 27067812
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell lung cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis.
    Zhou JG; Tian X; Cheng L; Zhou Q; Liu Y; Zhang Y; Bai YJ; Ma H
    Medicine (Baltimore); 2015 Oct; 94(40):e1719. PubMed ID: 26448029
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer.
    Chen YC; Chang YC; Ke WC; Chiu HW
    J Biomed Inform; 2015 Aug; 56():1-7. PubMed ID: 25998519
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Masitinib (AB1010), from canine tumor model to human clinical development: where we are?
    Marech I; Patruno R; Zizzo N; Gadaleta C; Introna M; Zito AF; Gadaleta CD; Ranieri G
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):98-111. PubMed ID: 24405856
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
    Balbin OA; Prensner JR; Sahu A; Yocum A; Shankar S; Malik R; Fermin D; Dhanasekaran SM; Chandler B; Thomas D; Beer DG; Cao X; Nesvizhskii AI; Chinnaiyan AM
    Nat Commun; 2013; 4():2617. PubMed ID: 24135919
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stage I non-small cell lung cancer: the presence of the lymphocyte-specific protein tyrosin kinase in the tumour infiltrate is associated with a better long-term prognosis.
    D'Andrilli A; Natoli G; Scarpino S; Rendina EA
    Interact Cardiovasc Thorac Surg; 2012 Jul; 15(1):148-51. PubMed ID: 22457183
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.